Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus

BACKGROUND: The risk of cardiovascular disease (CVD) in diabetes mellitus (DM) patients is two- to three-fold higher than in the general population. We designed a 10-year cohort trial in T2DM patients to explore the performance of QRESEARCH risk estimator version 3 (QRISK3) as a CVD risk assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Xiaodie, Wu, Aihua, Hu, Huiyue, Zhou, Hua, Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742415/
https://www.ncbi.nlm.nih.gov/pubmed/36518244
http://dx.doi.org/10.3389/fendo.2022.1077632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742415/
https://www.ncbi.nlm.nih.gov/pubmed/36518244
http://dx.doi.org/10.3389/fendo.2022.1077632

Ejemplares similares